Clinical Trial Update: Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Pfizer conducted a Phase 1/2 trial of bosutinib plus capecitabine in multiple solid tumors, including advanced breast cancer and pancreatic cancer; the study wa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cholangiocarcinoma
• Colorectal Cancer
• Glioblastoma Multiforme
• Pancreatic Cancer

Drugs mentioned

• Bosutinib (bosutinib)
• Capecitabine (capecitabine)

Snippet

Sponsor: Pfizer | Conditions: Advanced Breast Cancer (Parts 1 and 2), Advanced Pancreatic Cancer (Part 1) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-02-22